MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.220
-0.060 (-4.69%)
At close: Aug 28, 2026, 4:00 PM EDT
1.213
-0.008 (-0.61%)
After-hours: Aug 28, 2026, 7:30 PM EDT
MaxCyte Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, MaxCyte stock has a consensus rating of "Strong Buy" and an average price target of $4.11. The average 1-year stock price forecast is 236.89% higher than the current stock price, while the lowest is $2.43 (+99.18%) and the highest is $5.00 (+309.84%).
Price Target: $4.11 (+236.89%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for MaxCyte stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 24, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $4 | Buy | Maintains | $4 | +227.87% | Aug 13, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 13, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 2, 2026 |
Financial Forecast
Revenue This Year
31.45M
from 33.03M
Decreased by -4.79%
Revenue Next Year
37.18M
from 31.45M
Increased by 18.24%
EPS This Year
-0.28
from -0.36
EPS Next Year
-0.25
from -0.28
EPS and Forward PE are based on non-GAAP adjusted numbers.